Timigutuzumab (Anti-ERBB2 / HER2 / CD340)

Synonyms: GEXMab73

Timigutuzumab (Anti-ERBB2 / HER2 / CD340) is a humanized immunoglobulin that targets the extracellular domain of the human epidermal growth factor receptor 2 (ErbB2, also known as HER2). Timigutuzumab can be used for cancer research. MW: 150 KD.

Timigutuzumab (Anti-ERBB2 / HER2 / CD340)

Purity & Quality Control

≥99

Choose Selective EGFR Inhibitors

Biological Activity

Description Timigutuzumab (Anti-ERBB2 / HER2 / CD340) is a humanized immunoglobulin that targets the extracellular domain of the human epidermal growth factor receptor 2 (ErbB2, also known as HER2). Timigutuzumab can be used for cancer research. MW: 150 KD.

Product Details

CAS No. 1665274-14-5
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Timigutuzumab (Anti-ERBB2 / HER2 / CD340) | Timigutuzumab (Anti-ERBB2 / HER2 / CD340) supplier | purchase Timigutuzumab (Anti-ERBB2 / HER2 / CD340) | Timigutuzumab (Anti-ERBB2 / HER2 / CD340) cost | Timigutuzumab (Anti-ERBB2 / HER2 / CD340) manufacturer | order Timigutuzumab (Anti-ERBB2 / HER2 / CD340) | Timigutuzumab (Anti-ERBB2 / HER2 / CD340) distributor